Imran Talat
Chief Executive Officer
Imran Talat has filed 3 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 29, 2026.
On the most recent filing, Imran Talat is listed as Chief Executive Officer at Rani Therapeutics Holdings, Inc. Inside the rolling window, Imran Talat reported 1 open-market purchase totaling $25K in RANI and 1 open-market sale totaling $11K in RANI. The largest disclosed transaction in the window is a purchase of 35,000 RANI shares on Jul 17, 2026, worth $25K.
Companies traded
Other insiders at RANI
Insider Buying
$25K
reported purchases (SEC code P)
Insider Selling
$11K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Imran Talat made?
Imran Talat has filed 3 SEC Form 4 filings (9 transaction rows) across 1 company since 2026.
Which companies does Imran Talat trade?
Imran Talat has filed SEC Form 4 disclosures for 1 company, including RANI.
When was Imran Talat's most recent SEC Form 4 filing?
Imran Talat's most recent SEC Form 4 filing on Tracefour is dated Sep 29, 2026.
What is Imran Talat's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Imran Talat is listed as Chief Executive Officer.
What is Imran Talat's total buy and sell value in the current window?
Inside the rolling retention window, Imran Talat bought $25K and sold $11K based on SEC Form 4 filings.
What was Imran Talat's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 35,000 RANI shares on 2026-07-17, worth $25K, per SEC Form 4 filings.